Thermo Fisher Scientific (TMO)
EBITDA
$11.57B
TTM · Period ending: · USD
TMO EBITDA
Latest reported$11.57Bperiod ending
Latest reported$11.57Bperiod ending
TMO EBITDA ($12.70M → $11.57B)
Annual EBITDA
High-resolution chart · PNG
TMO ebitda history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| 11,466,000,000 | |
| 11,800,000,000 | |
| 11,195,000,000 | |
| 11,942,000,000 | |
| 11,969,000,000 | |
| 10,108,000,000 | |
| 7,023,000,000 | |
| 6,196,000,000 | |
| 5,054,000,000 | |
| 4,251,500,000 | |
| 4,039,500,000 | |
| 4,251,900,000 | |
| 2,581,700,000 | |
| 2,494,700,000 | |
| 2,184,200,000 | |
| 1,918,400,000 | |
| 1,832,500,000 | |
| 2,072,200,000 | |
| 1,777,900,000 | |
| 502,073,000 | |
| 435,885,000 | |
| 336,339,000 | |
| 279,300,000 | |
| 193,079,000 | |
| 265,425,000 | |
| 295,646,000 | |
| 362,200,000 | |
| 353,400,000 | |
| 371,600,000 | |
| 399,400,000 | |
| 332,300,000 | |
| 242,100,000 | |
| 166,000,000 | |
| 97,500,000 | |
| 61,700,000 | |
| 54,400,000 | |
| 30,500,000 | |
| 30,300,000 | |
| 17,600,000 | |
| 20,700,000 | |
| 12,700,000 |